QID 356591

Date Published: 2023-11-09

QID 356591: Amazon Linux Security Advisory for docker : ALAS2NITRO-ENCLAVES-2023-030

2023-10-31:( CVE-2023-24540 was added to this advisory. html/template: improper handling of javascript whitespace. not all valid javascript whitespace characters were considered to be whitespace.
Templates containing whitespace characters outside of the character set "\t\n\f\r\u0020\u2028\u2029" in javascript contexts that also contain actions may not be properly sanitized during execution. (
( CVE-2023-24540) the http/2 protocol allows a denial of service (server resource consumption) because request cancellation can reset many streams quickly, as exploited in the wild in august through october 2023. (
( CVE-2023-39325)



Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a securitybreach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as Critical - 9.8 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution
    Please refer to Amazon advisory: ALAS2NITRO-ENCLAVES-2023-030 for affected packages and patching details, or update with your package manager.
    Vendor References

    CVEs related to QID 356591

    CVE-2023-39325 | CVE-2023-24540 |
    Software Advisories
    Advisory ID Software Component Link
    ALAS2NITRO-ENCLAVES-2023-030 amazon linux 2 URL Logo alas.aws.amazon.com/AL2/ALASNITRO-ENCLAVES-2023-030.html
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].